SICKLE CELL DISEASE

Real-World Outcomes and Digitally Monitored Quality of Life in Voxelotor-Treated Patients with Sickle Cell Disease

Collaboration with Pfizer Ltd., American Society of Haematology Exposition (2023)

Areas of interest /
Outcomes research & novel therapeutic impacts

Biomarkers /
EQ-5D-5L, Activity, Sleep

Published in /
Blood Journal, American Society of Haematology

Contact

< Back to Sanius content

Real-World-Outcomes-and-Digitally-Monitored-Quality-of-Life-in-Voxelotor-Treated-Patients-with-Sickle-Cell-Disease-Blood-American-Society-of-Hematology